Billionaire Stan Druckenmiller’s Buys and Sells

DUQUESNE CAPITALBillionaire Stan Druckenmiller is one of the most successful hedge fund managers over the last 25 years. He stopped managing money for outsiders but he still manages funds for his family office. We get to his quarterly positions from 13F filings. Form 13F contains the list of positions held by hedge funds and institutional investors. By comparing Stanley Druckenmiller’s 13F filings from 4Q11 and 1Q12, we can learn which stocks he is recently buying and selling and how quickly positions were turned over and/or changed.

Stan Druckenmiller sold the following stocks during the first quarter of this year: Apple, Inc. (NASDAQ:AAPL), Ford Motor Co. (NYSE:F), JPMorgan Chase & Co. (NYSE:JPM), Johnson & Johnson (NYSE:JNJ), and Spectrum Pharmaceuticals, Inc. (NYSE:SPPI). These five positions accounted for 25% of the portfolio’s share count and 8% of its total value ($1.2 billion) at the close of 4Q11.

Druckenmiller has been a long time Apple fan but he probably decided to sell his shares after the stock surpassed the $500 billion market cap threshold. Apple is still the most popular stock among hedge funds despite some sells by prominent investors. Ford Motor Co. had a significant run-up in the middle of 4Q11, rising from approximately $9.30 to $12.50; it would later give these gains back in the latter half of the quarter. During 1Q12, Ford traded back up to $12.88, but is now back to $9.10. We think Ford is a great long-term stock pick even though it may keep showing some short term weakness due to the global slowdown.

Over the last year JP Morgan’s shares have descended by approximately 10%; it has underperformed for most of this period. Druckenmiller’s sale was timely but we think JP Morgan also presents a great long-term buying opportunity. Its CEO made a large insider purchase two weeks ago and we strongly recommended the stock at that time. The stock is up 6% since then.

There do not appear to be major sector plays. Aside from the sale of Ford, which we interpret as a rotation out of the domestic car market, the following additions to the portfolio indicate Druckenmiller retained exposure to all of the following sectors: technology, financials, and biotechnology/drugs. During the first quarter billionaire investor Stan Druckenmiller initiated large brand new positions in Qualcomm (NASDAQ:QCOM) and Wells Fargo (NYSE:WFC). He probably thought that QCOM is a better bet than Apple and Wells Fargo will outperform JP Morgan. Qualcomm lost 12% since the end of the first quarter vs. a 1% loss for Apple. Druckenmiller’s performance was better when it came to Wells Fargo. The stock only lost 1.4% whereas the losses at JP Morgan exceeded 20%.

Qualcomm has been showing strong  year over year growth numbers but the quarterly figures tell a different story. Revenues were up 28% y-o-y but down 6% sequentially. Net income is up 17% y-o-y but down 46% sequentially. Finally, earnings per share is up 13% y-o-y but down 46% sequentially. These short-term declines are influenced by the slowdown in Europe but we think these present an opportunity to initiate a long-term position. The company is the darling of hedge funds because of its huge growth prospects, yet it trades at a trailing PE ratio of 17. It has more than $26 billion in cash, cash equivalents and marketable securities and yields 1.7%. The company expects to earn around $3.64 in FY2012, giving it a forward PE ratio of less than 15 excluding cash. Billionaires Stephen Mandel, Ken Fisher, David Tepper and Leon Cooperman are among Qualcomm shareholders (see Lee Cooperman’s top picks).

The most notable position in Druckenmiller’s portfolio is the call options on Gold ETF (NYSEARCA:GLD). This acts as a hedge against the cyclical positions, as do certain restaurants whose positions were carried over from 4Q11 to 1Q12.  Taken together, we view the portfolio as cautiously optimistic.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!